Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration — DB-ACTIV  

Physical Inactivity Clinical Trial

Official title: Feasibility and Acceptability Study of a Non Weight-bearing Physical Activity Program for People With Diabetic Foot Ulceration (DB ACTIV)

Status Not yet recruiting

Clinical Trial Summary

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.

Clinical Trial Description

Objectives:

1. Evaluate the acceptability of a non-weight bearing physical activity (PA) program;

2. Assess the feasibility of the PA program and the data collection procedure;

3. Evaluate the feasibility of a submaximal exercise test for cardiorespiratory capacity; and

4. Verify the sensitivity of dependent variables to respond to a physical activity program (e.g., cardiorespiratory capacity, cardiovascular and metabolic risk factors, quality of life, PA level).

Type of study:

Feasibility and acceptability study with a pre-post evaluative design.

Intervention:

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.

Subjects:

• 10-12 persons with an active diabetic foot ulcer

• 2-3 kinesiologists

Data collection:

• Sociodemographic and health questionnaire (age, sex, gender, marital status, education level, employment status, average annual family income, medical and health history, pharmacological and non-pharmacological treatments);

• Feasibility assessment: PA (physical activity) logbook including 1) the number of supervised and unsupervised sessions completed, 2) the duration of each session, 3) participation rate (number of patients recruited/number of eligible patients), 4) attrition rate (number of participants who completed the follow-ups/number of participants recruited), and 5) perceived facilitators and barriers;

• Acceptability assessment: 1) Treatment Acceptability and Preference (TAP) Questionnaire, seven to nine additional questions to assess the use of provided material resources and required safety checks (capillary blood glucose and wound inspection) and collection of participants' feedback, and 2) Client Satisfaction Questionnaire (CSQ-8);

• Assessment of the sensitivity of dependent variables to respond to the PA program*: 1) estimation of VO2max by a submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), 2) average daily step count over seven days at the waist and in the offloading boot at times 0, 4, 8, and 12 weeks, 3) Global Physical Activity Questionnaire (GPAQ), 3) clinical examination (height, weight, body mass index, waist circumference, body fat percentage, blood pressure, resting heart rate, characteristics of the DFU and classification (SINBAD), 4) paraclinical examinations (venous blood glucose, glycated hemoglobin, lipid profile), 5) neuropathic pain questionnaire (DN4), 6) Epworth sleepiness scale, quality of life questionnaire (EQ-5D-5L), 7) questionnaire on motivation to practice PA.

• Health and safety parameter measurements: electrocardiogram, oxygen saturation, estimated glomerular filtration rate, urine albumin/creatinine ratio, complete blood count.

• Data collection at 24 and 36 weeks is also planned for participants who agree to be contacted after completing the 12-week PA program. ;

Related Conditions & MeSH terms

• Cardiopulmonary
• Diabetic Foot
• Foot Ulcer
• Physical Inactivity

• NCT number: NCT06092827
• Study type: Interventional
• Source: Université du Québec à Trois-Rivières
• Contact: Magali Brousseau-Foley, MD
• Phone: 819-372-5011
• Email: magali.brousseau-foley@uqtr.ca
• Status: Not yet recruiting
• Phase: N/A
• Start date: November 1, 2023
• Completion date: June 30, 2024